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ACRONYMS AND ABBREVIATIONS 
 
 
AIDS- Acquired immune deficiency syndrome 
 
ALT- Alanine transaminase 
ART- Antiretroviral therapy 
AZT- Zidovudine 
BMI- Body mass index 
 
CD4- Cluster of differentiation 
CHC-Community Health Centre 
CXR- Chest X-ray 
FBC- Full blood count 
 




KZN- Kwa-Zulu Natal 
LFT- liver function test 
NVP- Nevirapine 
  PHC- Primary health care 
 
PLWHA-people living with HIV/AIDS 
 
PMTCT- Prevention of mother to child transmission 
 
RPR- Rapid Plasma Reagin 
 






U&E – Urea and electrolyte 
 
UNAIDS- United Nations Aids Organisation 
 
VL- Viral load 
 
WHO- World Health Organisation 
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ABSTRACT / SUMMARY 
Introduction: South Africa has the highest number of HIV infected individuals in the 
world.
2 
The South African government has established National treatment guidelines for 
HIV positive patients to help ensure quality of care. The success of these guidelines 
depends on the commitment and level of adherence to them by hospitals and clinics. 
 
Aim: A descriptive study evaluating the standard of care received by HIV positive patients 
was undertaken at a community health centre in KwaDabeka, a semi-urban town in Kwa- 
Zulu Natal. This was benchmarked against the National ART Guidelines for 2010, which 
was the national policy at the time this study was undertaken. The objectives were to 
identify any deficiencies in the care of patients with HIV/AIDS, and to suggest possible 
solutions as well as to identify a demographic profile of the patients accessing care. 
 
 
Methods: The researcher selected three hundred and sixty patient files using a random 
process and then analyzed them. This sample size was calculated using a confidence 
interval of 95% of a total number of six thousand patients. Adult patients using ART for 
the period of 01 January 2011 until 31 December 2011 were only included. Pregnant 
patients and children were excluded from the study .The variables analyzed were generated 
using the pre-initiation, initiation and monitoring recommendations of the National ART 
Guidelines of 2010. A data sheet was drawn-up consisting of the various variables. This 
was analyzed using SPSS version 21. Simple descriptive statistics, univariate analysis, and 
frequency distribution tables were used to analyze the data. Tables, pie charts, and graphs 
have been used to represent the analyzed data. 
 
Results: Females comprised 65% and the mean patient age was 39 years. While the overall 
patient management was in accordance to the guidelines, there were major areas of con- 
compliance. These included the more than 80% of patients who did not have: pap smears; 
nutritional assessments; follow-up Tuberculosis (TB) symptom reviews; and mental health 
evaluations. In addition, there was a significant delay from obtaining a CD4 count to 
initiation of therapy of two months or longer in more than 50% of patients. Furthermore, 
the clinic did not comply with fast –tracking 84.5% of patients who needed to be initiated 
within two weeks of obtaining a CD4 count. Adverse events due to antiretroviral therapy 
were reported in approximately 41% of the patients, however, 25% did not have their 
regimen changed despite having a serious adverse event documented. The incidence of 
concurrent infection with TB was 32%, however none of the remaining non-infected 
patients (68%), received Isoniazid prophylaxis. 
 
Recommendations: The management of KwaDabeka CHC have significant challenges to 
overcome in order to optimise their treatment of HIV positive patients. Possible solutions 
must include access to the National ART Guidelines for all relevant health-care workers, 
regular medical update programmes on the management of HIV positive patients, and 







CHAPTER I: BACKGROUND 
South Africans have, in the past, encountered challenges that have tested the strength of 
the human spirit in ways that few other nations have experienced.
1 
The ray of optimism 
that accompanied the new democracy in 1994, which followed the fall of the former 
apartheid* regime, has since been threatened by a very different enemy. Today, South 
Africa often finds itself in the global spotlight for its huge burden of disease due to 
HIV/AIDS. In 2009, the United Nations estimated that 5.6 million South Africans are HIV 
positive, which is the largest number of infected individuals in any country, worldwide.
2
 
Anti-retroviral therapy (ART) has provided a ray of hope in the face of this scourge. 
Studies have revealed that ART has prevented millions of deaths globally.
4 
In a country 
like South Africa which has such a huge burden of HIV , ART may not only play a role in 
improving survival rates but also helping to maintain family units by decreasing the 
number of AIDS orphans. These young children face the daunting task of attempting to 
survive in a country facing many other challenges such as high levels of violent crime and 
unemployment. Furthermore, ART has also helped socio-economically by providing those 
afflicted with HIV an opportunity to remain positive contributors to society by reducing 
morbidity and disability. This study has highlighted key areas of improvement in the ART 
programme at Kwadabeka CHC, which if addressed, can make an enormous difference to 
both the physical and social well-being of this community. 
 
 
PROBLEM  STATEMENT 
Clinical guidelines for the management of HIV and AIDS in Adults compiled by the 
National Department of Health South Africa 2010, provides a step-by-step process for 
screening and initiating patients on treatment. However, whether these guidelines are being 
adhered to has not well established. It is possible that institutions, such as KwaDabeka 
Community Health Centre (appendix 1), which are often resource-limited, may find 
adherence to these guidelines more challenging. 
 
 
PURPOSE OF THE STUDY 
The study was conducted to determine if the National Guidelines (2010) for the 
management of HIV positive adult patients on ART was adhered to at Kwadabeka CHC 




1. To review the demographic profile of patients on antiretroviral therapy. 
2. To assess the level of adherence to National Treatment Guidelines for management of 
HIV positive patients. 
3. To identify the problems in the care of HIV positive patients on ART at a Community 
Health Centre. 
4. To make recommendations on ways to improve the quality of patient care. 
 
*apartheid: A system of racial segregation instituted by the National government of South Africa 








HIV/AIDS is one of the main challenges facing South Africa (SA) today.
3 
It is estimated 
that in 2010-2011, 72% (1.8 million) of deaths due to HIV infection are from sub-Saharan 
Africa, with at least 194 000 deaths in SA.
4
Antiretroviral therapy (ART) has increased the 
life expectancy of people living with HIV/AIDS (PLWHA).
5 
UNAIDS estimates that since 
2005, the advent of ART has prevented approximately 2.5 million deaths globally.
4 
In 
2011, SA is reported to have the largest ART programme in the world with 1.4 million 
PLWHA on ART and 30 000 new ART initiations per month.
6
In a study in the Western 
Cape, the initiation of ART had the effect of reducing the 6 month mortality from 12.7% to 





History of HIV and antiretroviral therapy (ART) in South Africa: 
 
The first confirmed case of HIV infection in South Africa was reported in 1982.
8 
The 
subsequent years saw an exponential rise of cases from 100 000 in the year 2000, to the 
current estimate stated above.
9 
Following the initial controversy regarding the provision of 
ART, the actual roll out was established in the public health sector in 2004.
10  
The 





This plan included the goals of increasing the number of new adults using ART from 120 
000 (24%), to 420 000 (80%) , the projected estimates at the time, as well as increasing the 
proportion of health facilities providing comprehensive HIV care, including ART, from 
10% to 80%. The provision of ART can be viewed, from these goals, as being a major 




The number of HIV positive South Africans utilising ART was estimated at 1.7 million in 
May 2011.
11 
This number on ART, the largest in the world, coupled with a need for a 
multi-disciplinary approach and the different levels of health-care facilities involved in the 
management of HIV positive patients, supports the need for national guidelines that 
standardise the care of these patients. The South African National Aids Council (SANAC) 
is responsible for drawing up the National Guidelines for the comprehensive management 




An analysis of the extent to which these National guidelines are being adhered to, 
particularly in a rural community, has yielded  important information regarding the 
challenges that face the treatment of HIV in a developing country such as South Africa. 
 
The principal investigator has conducted a clinical audit of the standard of care received by 
HIV positive patients on ART and has benchmarked this against the National treatment 
guidelines at a Community Health centre in KZN. 
9 
 
Results of previous audits: 
 
A clinical audit of the Prevention of Mother to child Transmission (PMTCT) programme at 
a regional hospital in South Africa in 2009 concluded that a significant proportion of HIV 
positive mothers did not have CD4 counts taken after testing positive and many were not 




Another audit of 
antenatal services in a rural clinic in KZN, found that at least one quarter of pregnant mothers 
did not enrol for the PMTCT programme.
14  
This is a significant number considering the 




A PUBMED search using the keywords: HIV positive patients, standards and quality care, 
audit, assessment, ART, KZN, South Africa and National Guidelines yielded few relevant 
studies that assessed the care of HIV positive patients. One study looked at the care of 
patients with TB/HIV/STI infections in a rural district in KZN. It found that weaknesses in 
training and support of staff at primary healthcare clinics (PHC), pharmaceutical and 
laboratory failures as well as inadequate monitoring of patients contributing to poor HIV 
service implementation.
16 
Another study, which utilised a file audit, to evaluate the 
retention in care and patient outcomes in a programme to decentralise ART to PHC 
facilities concluded that ‘PHC sites still needed to ensure that patients received CD4 and 
viral load monitoring six monthly’.
17 
A further shortfall noted was the unclear recording of 
adverse drug events in patients’ files.
17 
However, neither PUBMED nor Cochrane searches 
yielded any studies that analysed the standard of care of HIV positive patients when tested 
against the South African National Guidelines. 
 
A search for additional relevant publications was made in the South African Family 
Practitioners Journal, HIV Clinicians Society Journal and African PHC and FM Journals. 
One study that analyzed adherence to French National ART Guidelines was conducted in 
Paris. This study followed the management of one hundred and eighteen patients for the 
period of one year. The study revealed that the time for ART initiation was in agreement 
with National Guidelines for 54% of patients, 42% had started ART with CD4 counts of 
less than 200 copies/ml, 97% had treatment regimens in accordance with guidelines.
18 
A 
second study was Audit of the treatment of people with HIV in Britain according to their 
recommended guidelines. This study found that most patients were initiated on ART with 
CD4 counts lower than what had been recommended, 97% were on three or more drugs as 
per the guidelines.
19 
However, both these studies were carried out in developed countries 
that have a very different socio-economic and disease profile to South Africa. Further 
results revealed studies within South Africa and India that had looked at specific aspects of 
the ART programme for example; the initial regimens used or the side-effect profile of 






Implementation of National guidelines for HIV positive patients on ART in a socio- 
economically challenged country like South Africa, can be difficult, perhaps more so in a 
rural community. The lack of literature detailing the care of these patients further supports 
10 
 
the need for research in this domain. The results of an audit of this nature is anticipated to 
reveal not only major deficiencies in the treatment of HIV positive patients utilising ART, 
but also to indicate areas of improvement to managers of healthcare institutions and the 
KZN department of health. 
 
SUMMARY OF THE NATIONAL ART GUIDELINES 2010 
 
The National ART Guidelines 2010 recommend ART for HIV positive patients with CD4 
counts of less than 200 cell/mm
3 
or up to 350 cells/mm
3 
if co-infected with TB, have a 
stage 4 HIV illness( listed in appendix 4), or are diagnosed with MDR or XDR TB. Once 
eligibility for ART has been established, subsequent blood tests should be performed. 
These should include a FBC, U&E, LFT, and tests to exclude Hepatitis B and Syphilis 
infection. Female patients should have pap smears performed in order to exclude cervical 
cancer. All patients should have a sputum sample or chest x-ray taken to exclude TB. INH 
prophylaxis is recommended for those patients who are not co-infected with TB. A 
nutritional assessment that includes calculation of the BMI and a social assessment which 
evaluates living conditions, access to basic services e.g. running water and the financial 
situation of patients are required. These assist with assessing the need for disability grant 
provision as well as additional nutritional supplementation. All patients commencing ART 
should be placed on Bactrim prophylaxis. A treatment supporter has to be identified to 
improve compliance with treatment and a mental health review needs to be conducted as 
serious mental illness can result in poor adherence with therapy. The recommended first 
line triple drug regimens include TDF and 3TC and NVP/EFV or D4T and 3TC and 
EFV/NVP or AZT and 3TC and EFV/NVP. The second line therapy is reserved for failed 
first line therapy. Subsequent monitoring of blood tests will depend on the side-effect 
profile of the chosen regimen or the symptoms that the patients present with. At each 
subsequent visit patients need to be evaluated for new opportunistic infections especially 
TB. At six and twelve months CD4 counts and viral loads need to repeated. The Guidelines 
advise that the waiting time for patients with very low CD4 counts i.e. less than one 








This was a retrospective descriptive study. The category of study design used was an audit. 
 
Study location: 
KwaDabeka community health centre is a primary health care clinic situated within 
the municipal  boundary  of  EThekwini  (Durban).  It  serves  a  population  of  
approximately 
150000, predominantly black people. The residents of this district have a socio-economic 
profile similar to many rural communities within South Africa: poverty, unemployment, 
many informal homes with inadequate water supplies and poor sanitation, as well as a high 
prevalence of HIV/AIDS. The ARV clinic in KwaDabeka CHC has an estimated eight 
thousand patients registered and six thousand of whom already utilizing ART. This 
clinic is open on weekdays from 08h00am until 16h00pm. The patients are consulted, 
at least once per month, by either a nurse, doctor or both. There were three full-time CHC 
doctors assigned  to  the  HIV  clinic.  In  addition,  there  was  a  doctor,  employed  by  
a  non- governmental organisation, that did sessions at the HIV clinic. There was one 
nursing sister in charge with three professional nurses, two staff nurses and three enrolled 
nursing assistants. There were two adherence counsellors and two lay counsellors. The 
HIV clinic has its own clerk and the HIV positive patients’ charts were filed 
separately from the general out-patient files. There was one data capturer who was 
responsible for statistics and one social worker who was assigned to specifically manage 




The total number of HIV positive patients attending Kwadabeka CHC ,at the time of this 
study, was six thousand. This number consisted of men, women and children. Many of 
the patients accessing care at this institution reside in informal settlements.  The area is 
semi- urban so basic services such as running water and electricity remains a daily 
challenge. 
 
Sample size and strategy: 
The study sample included adult patients only who were on ART for at least one year. A 
minimum of one year was required to ensure that all the variables listed could be 
evaluated. The period analysed was 01 January 2011 until 31 December 2011 as this 
study was benchmarked against the National Guidelines of 2010 and it would be 
inaccurate to evaluate the management of patients prior to publication of these guidelines. 
Pregnant females and children were excluded because the PMTCT and Paediatric 
Guidelines for ART differ from the National Adult Guidelines. 
 
Patient charts are numbered and filed according to these numbers in filing cabinets. In 
order to obtain a sample size, the researcher first consulted with the biostatistician at 
UKZN. He emailed various online websites that provided tools to perform an online 
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sample calculation.The researcher used the Creative Research Systems website.
20  
The 
researcher chose a confidence level of 95% and a confidence interval of 5. A confidence 
level of 95% indicated that the researcher was 95% sure that the  study sample was 
representative of the total population of patients on ART at this clinic. A confidence 
interval or the margin of error is a plus-minus figure, often used in polls. The researcher 
chose a confidence interval of 5, so if for example the study revealed that 40% of the 
study population were males, for example, then it could then deduced that there was a 
95% confidence that the total percentage of males on ART at this CHC was between 35% 
(40- 
5) and 45% (40+5). This particular sample size calculator requires for both the 
confidence interval and level to be entered in order to generate a sample size. 
 
After entering this data the researcher was given a sample size of three hundred and 
sixty. In order to determine the interval between the files selected from the patient 
register,the total number of patients i.e six thousand was divided by three hundred and 
sixty which gave the researcher the number sixteen. This meant that in order to obtain a 
sample size of three hundred and sixty the researcher would have to select every 
sixteenth file after the first randomly selected file was chosen. This was done from the 
patient register for the period of 01 January 2011 to 31 December 2011. The numbers one 
to sixteen were written on individual pieces of paper and a number was selected using the 
lucky draw process. The number chosen had determined the first file selected. For 
example, if the number 4 was 
selected then the 4
th 
file on the patient register was chosen. Thereafter, every sixteenth 
file 
formed part of the sample. In order to analyse all the variables listed in the data collection 
tool  (appendix 2), the researcher only analyzed the files of patients who had been on ART 
for at least one year. In addition, pregnant females and children were excluded, as the 
PMTCT program has its own set of guidelines and the National guidelines for children 
differs from adults. In the event that a selected file belonged to a patient that had been on 
treatment for less than one year; a pregnant female, a child or if that file was missing, the 




The  2010  National  ART  Guidelines  was  divided  into  pre-initiation,  initiation  
and monitoring  recommendations.  In  order  to  compare  the  management  of  HIV  
positive patients at KwaDabeka CHC to these guidelines, which was the second objective 
of this study, in a systematic manner, the data collection tool (appendix 2) was also divided 
along the same lines. The following variables formed part of the first and subsequent 
visits (or pre-initiation) work-up as per National Guidelines: 
  Baseline CD4 counts: Taken at the time of being diagnosed with HIV. CD4 counts 




  Co-trimoxazole(Bactrim)  prophylaxis:  This  should  be  have  been  commenced  if  
a patient had a CD4 count of less than 200 copies/mm
3 
or in the presence of a stage 2, 




   Pap smear: All HIV positive females require cervical cancer screening upon diagnosis 
and if normal then three yearly irrespective of ART status. In this study, the researcher 
specifically looked at whether a pap smear was performed at all i.e. at the time of 
diagnoses, or subsequently, but within the range of the study period. 
 
  Mental health review: According to the National Guidelines, depression and anxiety       
is more common in HIV positive patients than HIV negative. The presence of 
mental 
illness  can  affect  adherence  to  treatment.  Furthermore,  patients  with  
untreated depression or on psychotropic drugs should not have been placed on 
Efavirenz as it could aggravate their symptoms. 
 
   TB screen: All HIV positive patients require screening for signs and symptoms of TB 
prior to ART. Ideally, a sputum specimen needs to be tested but if not possible then a 
chest x-ray should be ordered if TB symptoms are present. 
 
  Baseline bloods including a Hepatitis screen and RPR: These would include a 
full blood count, urea and electrolytes and liver function tests. Patients that have 
Hepatitis would require Tenofivir as part of their initial regimen. Syphilis is also a 
sexually transmitted infection and if present needs to be treated. 
 
 Nutritional assessment: Malnourished patients may require additional nutritional 
supplementation. Patients who experience unintentional weight loss of more than 1.5 
kilograms in one month may require screening for TB. 
 
   Social assessment: These assist with identifying the living conditions and establish 
if patient may need additional assistance for example social grants. 
 
  Treatment supporter: Disclosure to a close friend or partner is encouraged as HIV. 
This helps to improve adherence. 
 
   INH prophylaxis: TB preventive therapy is an effective intervention for HIV positive 
patients prior to ART initiation. 
 
The recommended timeline for fast-tracked patients for initiation of ART, as per 
National Guidelines, is two weeks, and the timeline variable helped to identify if this 
institution had complied. The patients that require fast tracking include CD4 counts of 
less than 100 copies/mm
3
; stage four illnesses irrespective of CD4 count and patients with 
MDR or XDR TB.  The initiation regimen variable was compared to that of the 
recommended regimens as per National Guidelines. The appropriateness of the regimen 
was then compared to the special  considerations  recommendations  in  the  National  
Guidelines.   For  example, Tenofivir  should  be  avoided  in  a  patient  with  a  
glomerular  filtration  rate  of  <  50 millilitres/min. The appropriate management of 
abnormal results variable compared the National Guidelines recommendations for drug-




The last aspect was monitoring. The data sheet used the following variables, which 
from part of the National Guidelines monitoring tools: 
 
 
 Follow-up clinical monitoring- TB symptom check (to exclude Immune reconstitution  
    syndrome). Patients needed to be screened for TB symptoms at every visit. The risk of  
    TB is highest around the time of initiation. 
 
 Follow-up bloods ( FBC, U&E, and LFT) in order to monitor for side effects. 
 
 Pill counts to check adherence. 
 
 Management of poor adherence as compared with the National guidelines 
   recommendations. 
 
 Immunological response- CD4 count and VL as per the National guidelines stipulated  




The first objective of this study was to establish a demographic patient profile and therefore 
the first two variables of the data sheet recorded gender and age. The third and fourth 
objectives of the study were achieved following the collection and analysis of data. The 
problems with implementation of National ART guidelines at this CHC have been 




Adult( defined as 18 years old and over) HIV positive patients utilizing ART from 
the period 01 January 2011 to 31 December 2011, at KwaDabeka CHC, and who had 








 Data collection methods and tools: 
The patient files selected in the sample was analyzed according to the variables that 
are listed on the data capture sheet (appendix 2). The patient management was compared to 
the recommended National ART guidelines of 2010, using these variables. The data 
collection tool had been piloted at KwaDabeka CHC, using a sample size of thirty patients. 
No modification to the tool was required. Data was captured on an Excel spreadsheet using 
categorical and numerical variables. 
 
 
Data Analysis techniques: 
The data obtained was entered into a computer using a Microsoft Excel spreadsheet and 
subsequently imported into SPSS version 21 for analysis. Simple descriptive statistics, 
15 
 
univariate analysis, and frequency distribution tables were used. Tables, pie charts, and 




1.   Information Bias: 
  Poor record keeping. 
  Lost results. 
Both the above factors may compromise the results of the audit. However, poor- 
record keeping and lost results provide some reasons for poor quality care. The 
intention of this study was to audit the standard of care and not to determine 
why this may have been. Hence, these factors were not individually analysed in 
the data collection tool. 
 
 
2.   External validity: This study was only undertaken at Kwadabeka CHC; 
therefore, generalizing the results to other CHC’s may not be possible. However, 
the results of  this  study  may  encourage  managers  of  other  institutions  to  
conduct  similar internal audits, which may help identify pitfalls of individual 




3.  The staffing levels and resources or structural criteria were not evaluated in 
this study. The National ART Guidelines do not provide recommended staff to 
patient ratios. This would make it impossible to assess if this CHC had 
complied with those recommendations or not and this has been, after all, a study 
directed at comparing  the  management  recommended  by  these  guidelines  with  




This protocol was submitted to both the Biomedical Research Ethics Committee as well as 
the Postgraduate Committees at UKZN for approval (appendix 3). Subsequent 
permission to conduct the proposed study was requested from the medical manager of 
KwaDabeka CHC. Permission from the Kwa-Zulu Natal Department of Health was also 
obtained both for the patient file audit as well as for the use of laboratory results prior 
to commencing this study. A waiver of informed consent to use patients’ medical records 
was not obtained. Patients were identified by numbers and not names and no potential harm 







A total number of 360 files were analysed. Forty of the initially selected sample did not 
meet the inclusion criteria. In order to ensure that the 360 files were met, forty additional 
files were selected, as per the process previously described under sampling strategy. 
The demographic profile of the patients is represented in figure 1. 
 
Figure 1: Gender distribution graph 
 
 
The mean age of the patients was 39 years. The age distribution has been illustrated in figure 
2. 
 
Figure 2: Age distribution histogram 
17 
 




TABLE 1 : Summary of the variables analyzed 
 
 YES NO NOT 
APPLICABLE 
Baseline CD4  count taken 352(97%) 8(3%) 0 
Staging of illness 355(98%) 5(2%) 0 
INH prophylaxis for patients 
without TB 
0 244(68%) 114(32%) 
Bactrim prophylaxis provided for 
stage 2, 3 or 4 illness or CD4 
count less than 200 copies/ml 
337(94%) 21(6%) 0 
Pap smear for all female patients 48(13%) 191(53%) 121(33%) 
Mental health review 0 360(100%) 0 
TB screen for all HIV positive 
patients prior to ART initiation 
316(96%) 11(3%) 0 
FBC, U&E and LFT∗  taken prior 
to ART initiation. 
347(97%) 12(3%) 0 
F/U TB review on subsequent 
visits post ART initiation 
55(15%) 291(82%) 11(3%) 
Vital signs checked at every visit 44(12%) 312(87%) 0 
BMI calculated 87(24%) 273(76%) 0 
Social assessment prior to ART 339(94%) 21(6%) 0 
Investigation of abnormal blood 
results 
29(8%) 45(13%) 285(79%) 
Adverse events 149(41%) 211(59%) 0 
New regimen initiated 124(34%) 234(65%) 0 
F/U Bloods taken 356(99%) 4(1%) 0 
Treatment supporter identified 355(99%) 5(1%) 0 
Pill counts taken on every visit 356(99%) 4(1%) 0 
 




Baseline CD4 counts were performed in 352 (97%) of patients. The mean CD4 count was 
125 copies/mm
3 
(SD 67). There was a total of 123 (34%) of patients whose baseline CD4 




Figure 3: Baseline CD4 distribution histogram 
 
 
The WHO staging of HIV (appendix 4) was used to classify patients’ stages of illness. A 
total number of 355 patients were staged and of these 152(42%), the majority, were 
classified as stage 1, 64(17.8%) were stage 2, 122(33.9%) were stage 3 while 17(4.7%) were 






Figure 4:  Patient distribution according to WHO staging 
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None of the patients were initiated on INH prophylaxis despite 244(68%) qualifying for it. 
The remainder 114(32%) were confirmed to have Tuberculosis (TB) and were taking anti- 
TB drugs. 
 
Pap smears had been performed on 48(20%) of female patients while 191(80%) did not have 
it done. 
 
Abnormal blood results were found in a total number of 74(20%) of the patients. Of these 74 
patients, 29(39%) had further investigations performed while the remaining 45(61%) did not 
have any active intervention. The other 285(79%) did not have abnormal blood results. 
Adverse events were documented in 149(42%) and of these 25% did not have their regimen 
changed despite having a serious adverse event documented.  Stavudine related 
lipodystrophy accounted for 104(70%) of adverse events while stavudine related peripheral 
neuropathy accounted for the remaining 30%. Regimen 1 was being used by 226(63%) and 
123(37%) were changed to regimen 2 due to adverse events (Table 2). 
 
 


































respectively (figures 5 and 6). The CD4 count was repeated at six months on 322(89%) of 

















The viral load at six months was undetectable in 28% of the patients and less than 40 
21 
 
copies/ml in 50% of patients (table 3). At twelve months, the viral load was undetectable 
in 38% and less than 40 copies/ml in 45% of the patients (table 3 below). 
 
      TABLE 3: Viral loads at six and twelve months 
 
 Undetectable <40copies/ml 
   
Viral load(6 months) 28% 50% 




The mean time interval from the taking of a CD4 count to the initiation of a patient on 
ART was 2.2 months and SD1.7. (figure 7). Twenty-one (15%) of patients were initiated on 











The study found that most patients on ART were female and between the ages of 30-48 
years (mean 39 and SD9). These finding were comparable with the United Nations AIDS 
findings for Sub-Saharan Africa published in the World AIDS day report in 2011.
21
 
The following steps as advised by the National Guidelines were adhered to by more than 
90% of the participants: performing a baseline CD4 count; staging the illness; 
commencement of Bactrim prophylaxis; screening for TB; conducting baseline blood tests; 
making social assessments; performing follow-up blood tests; ensuring a treatment 
supporter; and taking pill-counts on each visit. 
 
 
The steps that were not well adhered to included: lack of INH prophylaxis; poor percentage 
of pap-smears performed; no mental health evaluation conducted; poor follow- up of TB 
symptoms; lack of assessment of  vital signs and BMI; poor management of adverse drug 




INH prophylaxis was not issued to 68% of patients who qualified for it. This was despite 
the multiple studies, which have shown that INH prophylaxis reduced the incidence of TB 
in HIV-infected individuals by 62% in those with positive Tuberculin skin tests (TST) and 
by 11% in TST negative patients.
22 
The research findings suggest that the lack of 
adherence to INH prophylaxis may be attributable to a lack of knowledge of the guidelines. 
These findings require further investigation from the medical staff themselves. 
 
 
Pap smears were not performed on 191(80%) of the total number of females in this study. 
The relationship between HIV and cervical cancer has been well established. Abnormal 
cytology results have been reported in 65% of HIV positive women.
23  
Early detection of 
cervical cancer and prompt treatment makes a difference in mortality and morbidity. There 
is therefore a possibility that poor screening at this CHC may have resulted in pre-cancer 
and cancerous cervical cytology being missed in many females. 
 
 
The prevalence of depression or other psychiatric disorders in HIV positive patients has not 
been well established in Sub-Saharan Africa yet. However, one study in Tanzania found 
that 15% of HIV infected individuals had concurrent depression and 4.5% had other anxiety 
disorders.
24 
This article also mentioned that depression has been linked to faster disease 
progression and reduced drug adherence.It is therefore significant that none of the 
360 patients had any form of mental health assessment. The psychosocial implication as 
well as the stigma associated with HIV is well known. Many patients suffer with social 
alienation and its impact on mental health warrants attention. This audit could have 
brought to light much needed information about the possible concurrent existence of 
mental illness in HIV positive patients, had mental health assessments been conducted. 
However, if we had to draw similarities between South Africa and Tanzania, both of whom 
are emerging economies with resource limitation, this could imply that a significant
23 
 
percentage of mental illness may not have been diagnosed. 
 
The highest risk factor for TB is HIV infection. Patients who have commenced ART are at 
risk of experiencing clinical deterioration due to the inflammatory response against 
pathogens of which TB would be the most common. This is referred to as Immune 
Reconstitution Inflammatory Syndrome (IRIS). TB symptoms were not followed-up in 
82% of patients following the commencement of ART. This represents a significant 






Vital signs and BMI’s were not performed on at least 80% of patients. Vital signs usually 
consist of blood pressure, pulse and temperature recordings. Deranged vital signs may be a 
marker of acute illness. BMI assesses nutritional status. Many HIV infected patients are ill 
and malnourished at the time of ART initiation due to their vulnerable immune status and 
weight loss so the recording of vital signs and BMI would be very important. A study 
conducted in Burkina Faso can further support this as it had established a relationship 





A large number of adverse events were documented at the CHC (42%). These had related 
to the drug Stavudine, which was provided as first line therapy a few years ago. This 
finding is also supported by a study that had established Stavudine as the possible 
causative agent in 93% of adverse events.
27 
Fortunately, this drug, which had potentially 
life-threatening side-effects, has now been phased out in favour of the use of Tenofivir.
28
 
Adverse effects can result in mortality, morbidity and poor compliance. Therefore, patients 
need to be monitored for them. This was another area requiring attention at the CHC. 
 
 
The National Guidelines recommend a two-week interval from obtaining a CD4 count to 
ART initiation for patients with CD4 counts of less than 100 copies/mm
3
, patients with a 
stage 4 illness and those with XDR/MDR TB. There were 123(34%) who had CD4 counts 
of less than 100 copies/mm
3 
and 17(4.7%) with a stage 4 illness. This meant that 136 
patients needed to be fast-tracked i.e. commenced on treatment within two weeks. Twenty- 
one patients were commenced on treatment within two weeks which implies that 
115(84.5%) were not fast-tracked. 
 
The management of poor adherence was difficult to assess in this study. This was most 
likely because of scanty notes made on the actual steps taken to improve adherence. 
Patients that were suspected of being non-adherent with ART were referred to the 
adherence counsellors according to their files. The National ART Guidelines advise the 
methods listed below to improve adherence: 
• More visits and more frequent adherence checks. 
• Enlisting the support of family and friends. 
• Increasing home visits if possible. 
• Using reminders and reinforcing adherence tools. 
24 
 
• Actively addressing food security. 
 
The adherence counsellors had been consulted regarding this matter and they stated that they 
do employ the above methods with poorly adherent patients. However, it was not possible to 
ascertain if they had used these methods with the patients that were included in this study, 
due to lack of documentation in the files. 
 
The South African government has revised the National Strategic plan for the management 
of HIV, TB and STI’s for 2012-2016.
28 
The five goals that they hope to achieve are: 
 
• halving the number of new HIV infections 
• ensuring that at least 80% of people who are eligible for treatment for 
HIV is receiving it (at least 70% should be alive and still on treatment 
after five years) 
• halving the number of new TB infections and deaths from TB 
• ensuring that the rights of people living with HIV are protected 
• halving the stigma related to HIV and TB 
 
The manner that they propose to achieve these goals are quoted below.
28
 
• Address social and structural factors that drive these epidemics, influence their 
impact, and affect the way we care for affected people. 
• Prevent new HIV, STI’s and TB infections through a combination of interventions. 
• Sustain health and wellness, primarily by reducing deaths and disability from HIV 
infection and TB. 












The demographic profile generated reveals a predominant number of female patients and 
the average age of patients on ART was 39 years. 
The level of adherence to National ART Guidelines was poor. Specifically, six major areas 
were  identified with which the clinic did not comply in at least 50% of the patients 
sampled and has been discussed previously. 
 
The problems in the care of HIV positive patients at this CHC largely stem from the poor 
adherence with vital aspects of the guidelines, which this study was able to prove. 
Recommendations have been proposed. The overall impression was that the current 






The results of this study have revealed several aspects of the National Guidelines with 
which KwaDabeka CHC does not comply with. The researcher recommends that the 
management of this institution conduct an investigation to establish the reasons for this 
non-compliance. 
 
It may be advisable to ensure that copies of the National ART Guidelines is made available 
to the healthcare workers involved in the management of HIV positive patients. 
Staff meetings specifically addressing problems and concerns regarding the ART 
programme need to be held on a regular basis. 
Random auditing of patients’ files and presenting the results at staff meetings may identify 
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•Moderate unexplained weight loss (<10% of 
presumed or measured body weight) 
•Recurrent respiratory infections (sinusitis, 
tonsillitis, otitis media, and pharyngitis) 
•Herpes zoster 
•Angular cheilitis 
•Recurrent oral ulceration 
•Papular pruritic eruptions 
•Seborrheic dermatitis 




•Unexplained severe weight loss (>10% of 
presumed or measured body weight) 
•Unexplained chronic diarrhea for 
>1 month 
•Unexplained persistent fever for >1 month 
(>37.6°C, intermittent or constant) 
•Persistent oral candidiasis (thrush) 
•Oral hairy leukoplakia 
•Pulmonary tuberculosis (current) 
•Severe presumed bacterial infections (eg, 
pneumonia, empyema, pyomyositis,  
bone or joint  
infection, meningitis, bacteremia) 
•Acute necrotizing ulcerative stomatitis, 
gingivitis, or periodontitis 
•Unexplained anemia (hemoglobin <8 g/dL) 
•Neutropenia (neutrophils <500 cells/μL) 







•HIV wasting syndrome 
•Pneumocystis pneumonia  
•Recurrent severe bacterial pneumonia 
•Chronic herpes simplex infection (orolabial, 
genital, or anorectal site for >1 month or 
visceral  
herpes at any site) 
•Esophageal candidiasis (or candidiasis of 
trachea, bronchi, or lungs) 
•Extrapulmonary tuberculosis 
•Kaposi sarcoma 
•Cytomegalovirus infection (retinitis or 
infection of other organs) 
•Central nervous system toxoplasmosis 
•HIV encephalopathy 
•Cryptococcosis, ext 
rapulmonary (including meningitis) 
•Disseminated nontuberculosis Mycobacteria 
infection  
•Progressive multifocal leukoencephalopathy 
•Candida of the trachea, bronchi, or lungs 
•Chronic cryptosporidiosis (with diarrhea) 
•Chronic isosporiasis 
•Disseminated mycosis 
(eg, histoplasmosis, coccidioidomycosis, 
penicilliosis) 
•Recurrent nontyphoidal Salmonella 
bacteremia  
•Lymphoma (cerebral or B-cell non-
Hodgkin) 
•Invasive cervical carcinoma 
•Atypical disseminated leishmaniasis 
•Symptomatic HIV-associated nephropathy 
•Symptomatic HIV- 
associated cardiomyopathy 
•Reactivation of American trypanosomiasis 
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